Cargando…
Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere
SIMPLE SUMMARY: In addition to cancer-related factors, anti-cancer chemotherapy treatment can drive life-threatening body wasting in a syndrome known as cachexia. Emerging evidence has described the impact of several key chemotherapeutic agents on skeletal muscle in particular, and the mechanisms ar...
Autores principales: | Campelj, Dean G., Goodman, Craig A., Rybalka, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304349/ https://www.ncbi.nlm.nih.gov/pubmed/34298829 http://dx.doi.org/10.3390/cancers13143615 |
Ejemplares similares
-
Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia
por: Campelj, Dean G., et al.
Publicado: (2021) -
The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction
por: Campelj, Dean G., et al.
Publicado: (2020) -
Sodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice
por: Campelj, Dean G., et al.
Publicado: (2020) -
Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences
por: Campelj, Dean G., et al.
Publicado: (2021) -
BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice
por: Sorensen, James C., et al.
Publicado: (2017)